Join the DDA or

Molipaxin alert

Potential for contamination

January 4th 2018

Tagged: MHRA alert

By Ailsa Colquhoun

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 pharmacy, hospital, mental health trust and wholesaler level recall of Molipaxin 100mg capsules (trazodone) 1 x 56 capsules (Winthrop Pharmaceutical UK Limited trading as Zentiva)

The affected batch number and expiry date information is:

Batch no: 3650817

Expiry date: 07/2020

The recall is precautionary due to the potential that during manufacture of the batch, the metal detector may not have functioned and therefore that the presence of metal particles would not have been detected, if they were present.

Contractors are asked to return affected stock to your supplier.

For all the latest news of the 2018 DDA annual conference...

Learn more